|
SLC30A9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.09679973173627E-10 |
| Normal-vs-Stage3 |
6.21280804580238E-13 |
| Normal-vs-Stage4 |
5.06459985061269E-10 |
| Stage1-vs-Stage2 |
6.250400E-01 |
| Stage1-vs-Stage3 |
2.279200E-01 |
| Stage1-vs-Stage4 |
5.257200E-01 |
| Stage2-vs-Stage3 |
2.094400E-01 |
| Stage2-vs-Stage4 |
3.445400E-01 |
| Stage3-vs-Stage4 |
8.787200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
6.81676937119846E-14 |
| Normal-vs-Asian |
1.092300E-02 |
| Caucasian-vs-AfricanAmerican |
2.990800E-01 |
| Caucasian-vs-Asian |
3.802800E-01 |
| AfricanAmerican-vs-Asian |
2.281600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.64279700953784E-12 |
| Male-vs-Female |
2.366200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.62914126633495E-12 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
6.32827124036339E-15 |
| Normal-vs-Extreme_Obese |
1.897770E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.757200E-01 |
| Normal_Weight-vs-Obese |
2.344200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.411200E-01 |
| Extreme_Weight-vs-Obese |
9.971700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.479800E-01 |
| Obese-vs-Extreme_Obese |
8.701400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.15569800793492E-11 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
9.27991017363183E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.743000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.558800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.836800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.431200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.638800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.283200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.62592161956354E-12 |
| Normal-VS-KIRP CIMP |
2.40820030583677E-10 |
| Normal-VS-Unclassified PRCC |
3.91064958193965E-12 |
| Type1 PRCC-VS-Type2 PRCC |
2.925200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.550200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.915600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.637780E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.113400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.087800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-16 |
| Normal-vs-N1 |
6.03961325396085E-14 |
| Normal-vs-N2 |
1.030199999974E-06 |
| N0-vs-N1 |
6.924000E-01 |
| N0-vs-N2 |
6.715600E-01 |
| N1-vs-N2 |
8.047200E-01 |
|
|
